Gaudreault, Jacques <br/><br/>
Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.  [electronic resource] 

 -  Investigative ophthalmology & visual science  Feb 2005 
 - 726-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0146-0404 
<br/><br/><label>Standard No.: </label>10.1167/iovs.04-0601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized<br/>Aqueous Humor--metabolism<br/>Area Under Curve<br/>Biological Availability<br/>Drug Evaluation, Preclinical<br/>Female<br/>Half-Life<br/>Immunoglobulin Fab Fragments--immunology<br/>Injections<br/>Macaca fascicularis<br/>Male<br/>Ranibizumab<br/>Recombinant Fusion Proteins<br/>Retina--metabolism<br/>Vascular Endothelial Growth Factor A--immunology<br/>Vitreous Body--drug effects